Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

21.8K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
21.8K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delicate inhibition of NFκB/RELA circuitry facilitates efficient transition towards ground-state pluripotency in human.

Nature communications·2026
Same author

High-dose furmonertinib as first-line treatment for untreated EGFR-mutated advanced NSCLC with central nervous system metastases: A phase 2 trial.

Cell reports. Medicine·2026
Same author

Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.

Nature medicine·2026
Same author

Organoid modeling of lung branching morphogenesis and epithelial lineage specification.

Developmental cell·2026
Same author

Single-cell RNA sequencing reveals pancreatic cancer microenvironment heterogeneity for precision therapy.

Journal of translational internal medicine·2026
Same author

Single-cell RNA sequencing and high-dimensional flow cytometry reveal distinct peripheral immune landscapes of type 1 autoimmune pancreatitis and pancreatic ductal adenocarcinoma.

Clinical and translational medicine·2026

Related Experiment Video

Updated: Jun 3, 2025

Generation of Human Primordial Germ Cell-like Cells at the Surface of Embryoid Bodies from Primed-pluripotency Induced Pluripotent Stem Cells
12:06

Generation of Human Primordial Germ Cell-like Cells at the Surface of Embryoid Bodies from Primed-pluripotency Induced Pluripotent Stem Cells

Published on: January 11, 2019

12.3K

Capture primed pluripotency in guinea pig.

Jing Guo1, Runxia Lin2, Jinpeng Liu1

  • 1Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; CAS Key Laboratory of Regenerative Biology, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China, Guangzhou Medical University, Guangzhou 511436, China.

Stem Cell Reports
|January 10, 2025
PubMed
Summary
This summary is machine-generated.

Researchers developed guinea pig epiblast stem cells (gpEpiSCs), a novel tool for disease research. These cells maintain pluripotency and differentiate, enhancing the utility of guinea pigs in biomedical studies.

Keywords:
ACTIVIN AEpiSCsFGF2PSCsWNT signaling inhibitorsepigentic regulationgpEpiSCsguinea pigspluripotency markerspluripotent stem cellsteratoma formation

More Related Videos

Generation of Induced Pluripotent Stem Cells by Reprogramming Mouse Embryonic Fibroblasts with a Four Transcription Factor, Doxycycline Inducible Lentiviral Transduction System
11:48

Generation of Induced Pluripotent Stem Cells by Reprogramming Mouse Embryonic Fibroblasts with a Four Transcription Factor, Doxycycline Inducible Lentiviral Transduction System

Published on: November 13, 2009

24.6K
The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System
08:24

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System

Published on: February 28, 2017

6.9K

Related Experiment Videos

Last Updated: Jun 3, 2025

Generation of Human Primordial Germ Cell-like Cells at the Surface of Embryoid Bodies from Primed-pluripotency Induced Pluripotent Stem Cells
12:06

Generation of Human Primordial Germ Cell-like Cells at the Surface of Embryoid Bodies from Primed-pluripotency Induced Pluripotent Stem Cells

Published on: January 11, 2019

12.3K
Generation of Induced Pluripotent Stem Cells by Reprogramming Mouse Embryonic Fibroblasts with a Four Transcription Factor, Doxycycline Inducible Lentiviral Transduction System
11:48

Generation of Induced Pluripotent Stem Cells by Reprogramming Mouse Embryonic Fibroblasts with a Four Transcription Factor, Doxycycline Inducible Lentiviral Transduction System

Published on: November 13, 2009

24.6K
The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System
08:24

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System

Published on: February 28, 2017

6.9K

Area of Science:

  • Developmental Biology
  • Stem Cell Biology
  • Comparative Genomics

Background:

  • Guinea pigs are valuable models for human disease research.
  • Lack of established pluripotent stem cell lines has limited their utility.
  • Need for advanced stem cell tools in guinea pig models.

Purpose of the Study:

  • To isolate and characterize guinea pig epiblast stem cells (gpEpiSCs).
  • To establish a new stem cell line for biomedical research.
  • To enhance the utility of guinea pigs in studying human diseases.

Main Methods:

  • Isolation and characterization of gpEpiSCs from post-implantation embryos.
  • Assessment of differentiation potential into three germ layers.
  • Karyotype analysis, gene expression profiling (pluripotency markers), and epigenetic analysis.

Main Results:

  • Successfully isolated and characterized gpEpiSCs, which maintain normal karyotypes.
  • GpEpiSCs self-renew and maintain pluripotency dependent on FGF2, ACTIVIN A, and WNT inhibition.
  • Transcriptional and epigenetic analyses reveal similarities and differences with human/mouse primed stem cells, indicating conserved and divergent pathways.

Conclusions:

  • Established guinea pig epiblast stem cells (gpEpiSCs) as a viable pluripotent stem cell line.
  • Demonstrated evolutionary conservation and divergence in primed pluripotent stem cells.
  • Provides a novel tool for biomedical research, enhancing guinea pig models for human disease study.